通策医疗
(600763)
| 流通市值：162.27亿 | | | 总市值：162.27亿 |
| 流通股本：4.44亿 | | | 总股本：4.44亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 2,501,468,689.46 | 1,586,118,351.78 | 755,289,213.29 | 2,913,101,528.81 |
| 营业总成本 | 1,738,959,209.67 | 1,116,871,540.34 | 528,626,816.22 | 2,250,412,202.89 |
| 其他经营收益 | | | | |
| 营业利润 | 896,630,840.44 | 600,450,727.05 | 242,145,066.69 | 708,012,052.36 |
| 利润总额 | 892,991,921.64 | 598,239,370.29 | 241,752,368.6 | 705,355,785.2 |
| 净利润 | 779,957,062.11 | 520,708,846.72 | 220,580,134.55 | 588,289,970.81 |
| 每股收益 | | | | |
| 其他综合收益 | -1,552,067.28 | -2,409,741.83 | -0.12 | -94,310,428.95 |
| 综合收益总额 | 778,404,994.83 | 518,299,104.89 | 220,580,134.43 | 493,979,541.86 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 1,081,082,362.59 | 817,465,833.01 | 1,179,667,772.41 | 1,140,362,133.19 |
| 非流动资产: | | | | |
| 非流动资产合计 | 5,168,030,195.49 | 5,172,041,860.11 | 5,059,397,496.42 | 5,020,551,352.56 |
| 资产总计 | 6,249,112,558.08 | 5,989,507,693.12 | 6,239,065,268.83 | 6,160,913,485.75 |
| 流动负债: | | | | |
| 流动负债合计 | 857,831,099.08 | 727,946,320.51 | 688,789,259.44 | 758,037,668.5 |
| 非流动负债: | | | | |
| 非流动负债合计 | 700,764,068.06 | 732,823,193.58 | 764,023,700.52 | 782,567,295.69 |
| 负债合计 | 1,558,595,167.14 | 1,460,769,514.09 | 1,452,812,959.96 | 1,540,604,964.19 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 4,254,053,215.97 | 4,136,586,725.49 | 4,420,895,942.57 | 4,285,170,856.34 |
| 股东权益合计 | 4,690,517,390.94 | 4,528,738,179.03 | 4,786,252,308.87 | 4,620,308,521.56 |
| 负债和股东权益合计 | 6,249,112,558.08 | 5,989,507,693.12 | 6,239,065,268.83 | 6,160,913,485.75 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 2,556,817,479.87 | 1,615,622,299.98 | 703,109,568.55 | 2,914,357,126.49 |
| 经营活动现金流出小计 | 1,770,625,896.54 | 1,215,271,746.78 | 542,145,980.63 | 2,103,638,499.81 |
| 经营活动产生的现金流量净额 | 786,191,583.33 | 400,350,553.2 | 160,963,587.92 | 810,718,626.68 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 15,699,844.84 | 14,590,595.44 | - | 16,483,333.85 |
| 投资活动现金流出小计 | 798,069,924.65 | 709,704,928.94 | 80,591,875 | 295,722,479.89 |
| 投资活动产生的现金流量净额 | -782,370,079.81 | -695,114,333.5 | -80,591,875 | -279,239,146.04 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 450,000,000 | 300,000,000 | 250,000,000 | 68,524,741 |
| 筹资活动现金流出小计 | 533,543,889.43 | 335,426,284.64 | 234,754,599.59 | 523,545,454.59 |
| 筹资活动产生的现金流量净额 | -83,543,889.43 | -35,426,284.64 | 15,245,400.41 | -455,020,713.59 |
| 汇率变动对现金及现金等价物的影响 | -0.21 | -0.21 | -0.11 | -0.16 |
| 现金及现金等价物净增加额 | -79,722,386.12 | -330,190,065.15 | 95,617,113.22 | 76,458,766.89 |
| 期末现金及现金等价物余额 | 617,293,195.85 | 366,825,516.82 | 791,934,559.69 | 696,317,446.47 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -330,190,065.15 | - | 76,458,766.89 |
最新报告期：2026-10-30| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 华安证券 | 谭国超 | 1.43 | 1.45 | 1.57 | 2026-10-30 |
| 开源证券 | 阮帅,余汝意 | 1.73 | 1.88 | 2.07 | 2026-10-30 |
| 中金公司 | 夏璐,张琎,朱言音 | 1.30 | 1.44 | -- | 2026-10-29 |
| 华泰证券 | 代雯,高鹏 | 1.49 | 1.53 | 1.66 | 2026-10-28 |
| 中信建投 | 吴严,刘慧彬,王在存,贺菊颖 | 1.46 | 1.48 | 1.65 | 2026-10-01 |